adenosine monophosphate has been researched along with Hemorrhagic Fever, Ebola in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (41.67) | 24.3611 |
| 2020's | 14 (58.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bannister, R; Bavari, S; Cihlar, T; Donnelly, G; Garza, NL; Gomba, L; Iversen, PL; Kane, CD; Norris, S; Porter, DP; Steffens, J; Stuthman, KS; Van Tongeren, SA; Warren, TK; Weidner, JM; Wells, J; Zeng, X | 1 |
| Fujita, Y | 1 |
| Abelson, DM; Agans, KN; Borisevich, V; Bornholdt, ZA; Bunyan, E; Campbell, LA; Cross, RW; Deer, DJ; Dobias, NS; Fenton, KA; Geisbert, JB; Geisbert, TW; Kim, DH; Porter, DP; Prasad, AN; Shestowsky, WS; Woolsey, C; Zeitlin, L | 1 |
| Bilello, JP; Chan, J; Chia, JJ; Cihlar, T; Cowfer, D; Feng, JY; Gong, R; Iversen, P; Kaptein, SJF; Leventhal, SM; Lu, X; Neyts, J; Porter, DP; Radoshitzky, SR; Sapre, AA; Shi, PY; Shornikov, A; Song, ZJ; Steffens, J; Stuthman, KS; Truong, H; Van Tongeren, SA; Warren, T; Wells, J; Xie, X; Yang, H; Yu, H; Zhang, X; Zou, J | 1 |
| Lucey, DR | 1 |
| Aboulhab, J; Ahuka, S; Albert, S; Ali, R; Barrett, K; Bonnett, T; Cahill, K; Camara, M; Cao, H; Cone, K; Coulibaly, S; Crozier, I; Davey, RT; Diaz, J; Dighero-Kemp, B; Dodd, LE; Duvenhage, M; Eckes, R; Gettinger, N; Grais, R; Hensley, L; Herpin, B; Higgs, E; Holman, W; Ibanda, A; Kojan, R; Lane, HC; Ledgerwood, J; Levine, AC; Lusakibanza Manzo, M; Mbala-Kingebeni, P; Moench, T; Mukadi, D; Mukumbayi, P; Mulangu, S; Muyembe-Tamfum, JJ; Nordwall, J; Nzolo, D; Pierson, J; Proffitt, C; Proschan, M; Sivahera, B; Sivapalasingam, S; Smolskis, M; Sow, Y; Teitelbaum, M; Tierney, J; Tshiani Mbaya, O; Tshomba Oloma, A; Vallée, D; Walker, R | 1 |
| Antonucci, M; Avataneo, V; Cusato, J; D'Avolio, A; de Nicolò, A; di Perri, G; Lamorde, M; Manca, A; Palermiti, A; Waitt, C; Walimbwa, S | 1 |
| Feldmann, H; Geisbert, TW; Sprecher, A | 1 |
| Kaltenboeck, A; Kesselheim, AS; Sarpatwari, A | 1 |
| Fätkenheuer, G; Malin, JJ; Priesner, V; Rybniker, J; Suárez, I | 1 |
| Farbod, A; Mahmoudi, H; Mozafarihashjin, M; Neishabouri, A; Nili, A; Tavakolpour, S | 1 |
| Carafoli, E; Santoro, MG | 1 |
| Aboulhab, J; Beavogui, AH; Cao, H; Cihlar, T; Fischer Ii, WA; Gayedyu-Dennis, D; Hensley, L; Higgs, ES; Lane, HC; Lobbo, P; Nason, M; Nordwall, J; Reilly, C; Wachekwa, I | 1 |
| Aliota, MT; Bonnac, LF; Geraghty, RJ | 1 |
| Muller, FL; Yan, VC | 1 |
| Deng, F; Ding, Q; Gan, T; Gao, H; Gong, M; Huang, W; Huang, Y; Li, Q; Nie, J; Rao, Y; Wang, Y; Wu, Y; Yang, Y; Zhang, R; Zhong, J | 1 |
| Check Hayden, E | 1 |
| Nakkazi, E | 1 |
| Babusis, D; Bannister, R; Barauskas, O; Bavari, S; Braun, MR; Carra, E; Chen, SS; Chun, K; Cihlar, T; Clarke, MO; Doerffler, E; Donnelly, G; Eaton, BP; Fearns, R; Feng, JY; Flint, M; Garza, NL; Gharaibeh, D; Gomba, L; Grimes, E; Hui, HC; Jordan, R; Kenny, T; Kugelman, JR; Larson, N; Lee, WA; Lew, W; Lo, MK; Mackman, RL; Mayers, DL; McMullan, LK; Nagle, ER; Neville, S; Nichol, ST; Nichols, DK; Nuss, JE; Palacios, G; Park, Y; Perron, M; Ray, AS; Retterer, CJ; Ross, B; Shurtleff, AC; Siegel, D; Soloveva, V; Spiropoulou, CF; Stray, KM; Strickley, R; Stuthman, KS; Swaminathan, S; Trancheva, I; Van Tongeren, SA; Wang, Q; Warren, TK; Welch, LS; Wells, J; Wilhelmsen, CL; Wolfe, L; Wong, P; Xu, Y; Zamani, R; Zhang, L | 1 |
| Bell, DJ; Bhagani, S; Cropley, I; Filipe, A; Gifford, RJ; Gopal, R; Hopkins, S; Hughes, J; Jabeen, F; Jacobs, M; Johannessen, I; Karageorgopoulos, D; Lackenby, A; Lester, R; Liu, RS; MacConnachie, A; Mahungu, T; Marshall, N; Martin, D; Mepham, S; Orton, R; Palmarini, M; Patel, M; Perry, C; Peters, SE; Porter, D; Ritchie, D; Ritchie, ND; Rodger, A; Seaton, RA; Sreenu, VB; Templeton, K; Thomson, EC; Warren, S; Wilkie, GS; Zambon, M | 1 |
| Bavari, S; Cardile, AP; Martins, KA; Reisler, RB; Warren, TK | 1 |
| Antierens, A; Burzio, C; Caluwaerts, S; De Clerck, H; Dörnemann, J; Kolié, MC; McElroy, AK; Ronsse, A; Sprecher, A; Van Herp, M; Yosifiva, V | 1 |
| Bannister, R; Barauskas, O; Bavari, S; Carra, E; Chun, K; Cihlar, T; Clarke, MO; Doerffler, E; Feng, JY; Hui, HC; Jordan, R; Knox, J; Lee, G; Lee, WA; Lew, W; Lo, MK; Mackman, RL; Neville, S; Perron, M; Perry, J; Ray, AS; Rheingold, AL; Ross, B; Siegel, D; Soloveva, V; Stray, KM; Strickley, R; Swaminathan, S; Wang, Q; Warren, TK; Wolfe, L; Xu, Y; Zhang, L | 1 |
6 review(s) available for adenosine monophosphate and Hemorrhagic Fever, Ebola
| Article | Year |
|---|---|
Ebola.
Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Disease Outbreaks; Ebola Vaccines; Ebolavirus; Hemorrhagic Fever, Ebola; Humans | 2020 |
Remdesivir against COVID-19 and Other Viral Diseases.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Compassionate Use Trials; Coronavirus Infections; COVID-19; Drug Administration Schedule; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; Patient Safety; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Survival Analysis; Treatment Outcome | 2020 |
Remdesivir: A beacon of hope from Ebola virus disease to COVID-19.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; SARS-CoV-2; Treatment Outcome; Virus Replication | 2020 |
Remdesivir: From Ebola to COVID-19.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19 Drug Treatment; Drug Discovery; Hemorrhagic Fever, Ebola; Humans | 2021 |
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues.
Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; COVID-19 Drug Treatment; Hemorrhagic Fever, Ebola; Humans; Middle East Respiratory Syndrome Coronavirus; Mutagenesis; Nucleosides; Pyrazines; Ribavirin; SARS-CoV-2; Virus Replication; Zika Virus; Zika Virus Infection | 2021 |
Will There Be a Cure for Ebola?
Topics: Adenine; Adenosine; Adenosine Monophosphate; Africa, Western; Alanine; Animals; Antiviral Agents; Disease Outbreaks; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Purine Nucleosides; Pyrrolidines; Ribonucleotides | 2017 |
3 trial(s) available for adenosine monophosphate and Hemorrhagic Fever, Ebola
| Article | Year |
|---|---|
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
Topics: Adenosine Monophosphate; Adolescent; Adult; Alanine; Antibodies, Monoclonal; Antiviral Agents; Child; Child, Preschool; Democratic Republic of the Congo; Disease Outbreaks; Ebolavirus; Female; Hemorrhagic Fever, Ebola; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Ribonucleotides; RNA, Viral; Single-Blind Method; Young Adult | 2019 |
PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors.
Topics: Adenosine Monophosphate; Alanine; Double-Blind Method; Ebolavirus; Female; Follow-Up Studies; Hemorrhagic Fever, Ebola; Humans; Male; RNA; Semen; Survivors | 2021 |
Randomised controlled trial begins for Ebola therapeutics.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Child, Preschool; Democratic Republic of the Congo; Ebolavirus; Feasibility Studies; Female; Hemorrhagic Fever, Ebola; Humans; Infant; Infant, Newborn; Male; Ribonucleotides; Treatment Outcome | 2018 |
15 other study(ies) available for adenosine monophosphate and Hemorrhagic Fever, Ebola
| Article | Year |
|---|---|
Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus.
Topics: Adenosine Monophosphate; Administration, Intravenous; Aerosols; Alanine; Animals; Antiviral Agents; Disease Models, Animal; Ebolavirus; Female; Hemorrhagic Fever, Ebola; Kaplan-Meier Estimate; Liver; Lung; Lymph Nodes; Macaca mulatta; Male; Random Allocation; Systemic Inflammatory Response Syndrome; Viral Load; Viremia | 2021 |
[Remdesivir for COVID-19].
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19 Drug Treatment; Hemorrhagic Fever, Ebola; Hepatitis C, Chronic; Humans; SARS-CoV-2 | 2022 |
Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease.
Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal; Antibodies, Viral; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Macaca mulatta; Marburgvirus; Virus Diseases | 2022 |
Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Filoviridae; Hemorrhagic Fever, Ebola; Humans; Zika Virus; Zika Virus Infection | 2023 |
New treatments for Ebola virus disease.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Antiviral Agents; Blood-Brain Barrier; Democratic Republic of the Congo; Ebolavirus; Epidemics; Hemorrhagic Fever, Ebola; Humans; Infusions, Intravenous; International Cooperation; Randomized Controlled Trials as Topic; Ribonucleotides | 2019 |
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Alanine; Betacoronavirus; Chromatography, High Pressure Liquid; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Hemorrhagic Fever, Ebola; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Sensitivity and Specificity; Tandem Mass Spectrometry | 2020 |
Missed Opportunities on Emergency Remdesivir Use.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials, Phase III as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Costs; Drugs, Investigational; Hemorrhagic Fever, Ebola; Humans; Length of Stay; National Institute of Allergy and Infectious Diseases (U.S.); Pandemics; Pneumonia, Viral; Registries; SARS-CoV-2; Treatment Outcome; United States | 2020 |
Why Remdesivir Failed: Preclinical Assumptions Overestimate the Clinical Efficacy of Remdesivir for COVID-19 and Ebola.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19 Drug Treatment; Hemorrhagic Fever, Ebola; Humans; Macaca mulatta; SARS-CoV-2; Treatment Outcome | 2021 |
Novel quinolone derivatives targeting human dihydroorotate dehydrogenase suppress Ebola virus infection in vitro.
Topics: Adenosine Monophosphate; Africa, Western; Alanine; Antiviral Agents; Cell Line; Dihydroorotate Dehydrogenase; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Inhibitory Concentration 50; Quinolones; Virus Replication | 2021 |
Experimental drugs poised for use in Ebola outbreak.
Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal; Congo; Disease Outbreaks; Drugs, Investigational; Ebola Vaccines; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Internationality; Pyrazines; Ribonucleotides | 2018 |
Public health round-up.
Topics: Adenosine Monophosphate; Alanine; Aminoisobutyric Acids; Anti-Bacterial Agents; Antibodies, Monoclonal; Benzimidazoles; Cyclopropanes; Democratic Republic of the Congo; Disease Outbreaks; Drug Resistance, Bacterial; Global Health; Hemorrhagic Fever, Ebola; Hepatitis C; Humans; Interinstitutional Relations; Lactams, Macrocyclic; Leucine; Malaria; Measles; Measles Vaccine; Poliomyelitis; Proline; Public Health Practice; Pyrrolidines; Quinoxalines; Randomized Controlled Trials as Topic; Ribonucleotides; Sulfonamides; Tuberculosis | 2019 |
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.
Topics: Adenosine Monophosphate; Alanine; Amino Acid Sequence; Animals; Antiviral Agents; Cell Line, Tumor; Ebolavirus; Female; HeLa Cells; Hemorrhagic Fever, Ebola; Humans; Macaca mulatta; Male; Molecular Sequence Data; Organ Specificity; Prodrugs; Ribonucleotides | 2016 |
Late Ebola virus relapse causing meningoencephalitis: a case report.
Topics: Acute Disease; Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Cranial Nerve Diseases; Disease Outbreaks; Drugs, Investigational; Ebolavirus; Female; Genome, Viral; Hemorrhagic Fever, Ebola; Humans; Meningoencephalitis; Nurses; Radiculopathy; Recurrence; Ribonucleotides; RNA, Viral; Scotland; Sierra Leone; Viral Load | 2016 |
First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Antiviral Agents; Blood; Female; Hemorrhagic Fever, Ebola; Humans; Immunologic Factors; Infant, Newborn; Pregnancy; Ribonucleotides; Therapies, Investigational; Treatment Outcome; Young Adult | 2017 |
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses.
Topics: Adenosine Monophosphate; Alanine; Amides; Cell Line; Drug Discovery; Hemorrhagic Fever, Ebola; Humans; Microbial Sensitivity Tests; Phosphoric Acids; Prodrugs; Ribonucleotides; Structure-Activity Relationship; Virus Diseases | 2017 |